| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |